MedTrace Logo

Prizvalve Pro™ Transcatheter Aortic Valve Replacement Study

NCT05864456 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2023-11-18

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the safety and efficacy of the Prizvalve Pro™ transcatheter aortic valve system in the treatment of patients with severe aortic stenosis who are at high risk of surgery or who are not suitable for surgery.

Conditions

  • Aortic Valve Stenosis

Interventions

DEVICE

Prizvalve Pro™ transcatheter aortic valve system

Transcatheter Aortic Valve Replacement

Sponsors & Collaborators

  • The General Hospital of Northern Theater Command

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • Shanghai NewMed Medical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Yaling Han, Professor · Principal coordinating investigator

  • Mao Chen, Professor · coordinating investigator

  • Kai Xu, Professor · coordinating investigator

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-05
Primary Completion
2024-06-30
Completion
2028-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05864456 on ClinicalTrials.gov